Investing.com - Qiagen (NYSE:QGEN) reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Qiagen announced earnings per share of $0.31 on revenue of $344.62M. Analysts polled by Investing.com anticipated EPS of $0.24 on revenue of $310.42M. That with comparison to EPS of $0.24 on revenue of $311.63M in the same period a year before. Qiagen had reported EPS of $0.44 on revenue of $375.84M in the previous quarter. Analysts are expecting EPS of $0.28 and revenue of $330.62M in the upcoming quarter.
Qiagen shares are up 26% from the beginning of the year , still down 1.63% from its 52 week high of $39.19 set on December 2, 2019. They are outperforming the STOXX 600 which is down 19.12% year to date.
Qiagen follows other major Healthcare sector earnings this month
Qiagen's report follows an earnings beat by Bayer on April 27, who reported EPS of $2.67 on revenue of $12.85B, compared to forecasts EPS of $2.52 on revenue of $12.57B.
Siemens Healthineers had beat expectations on Tuesday with second quarter EPS of $0.43 on revenue of $3.69B, compared to forecast for EPS of $0.4 on revenue of $3.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar